ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Armata Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$3.07−0.30 (-8.90%)
Close on Oct 19, 2026
- Market cap
- $190.47M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2019(first seen in filings) | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| May 10, 2019 | 1-for-14 reverse | Earlier per-share figures multiplied by 14 |
| Apr 25, 2017 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Apr 24, 2017 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 7, 2015 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Aug 3, 2015 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| May 11, 2006 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |